17 results

  • betamethasone dipropionate

    (Betamethasone Dipropionate)
    Taro Pharmaceuticals U.S.A., Inc.
    Betamethasone dipropionate cream is a medium-potency corticosteroid indicated for relieving inflammation and itching associated with corticosteroid-responsive skin conditions in patients aged 13 and older.

  • clindamycin phosphate

    (Clindamycin Phosphate)
    Taro Pharmaceuticals U.S.A., Inc.
    Clindamycin phosphate topical lotion is indicated for the treatment of acne vulgaris. Physicians should evaluate the risk of diarrhea and colitis before prescribing it, considering alternative treatments if necessary.

  • clindamycin phosphate and benzoyl peroxide

    (Clindamycin Phosphate and Benzoyl Peroxide)
    Taro Pharmaceuticals U.S.A., Inc.
    Clindamycin phosphate and benzoyl peroxide gel, 1.2%/3.75%, is indicated for the topical treatment of acne vulgaris in patients aged 12 years and older.

  • clotrimazole

    (Clotrimazole)
    Taro Pharmaceuticals U.S.A., Inc.
    This drug is indicated for the treatment of athlete's foot (tinea pedis), jock itch (tinea cruris), and ringworm (tinea corporis), providing effective relief from associated symptoms such as itching, cracking, burning, and discomfort.

  • econazole nitrate

    (Econazole Nitrate)
    Taro Pharmaceuticals U.S.A., Inc.
    Econazole nitrate cream is indicated for topical treatment of tinea pedis, tinea cruris, tinea corporis, cutaneous candidiasis, and tinea versicolor, caused by various fungi including *Trichophyton* and *Microsporum* species.

  • fluocinolone acetonide

    (Fluocinolone Acetonide)
    Taro Pharmaceuticals U.S.A., Inc.
    Fluocinolone acetonide topical oil is a low to medium potency corticosteroid indicated for the treatment of psoriasis of the scalp in adult patients.

  • fluocinolone acetonide

    (Fluocinolone Acetonide)
    Taro Pharmaceuticals U.S.A., Inc.
    Fluocinolone acetonide topical oil is indicated for the treatment of atopic dermatitis in adults and moderate to severe atopic dermatitis in pediatric patients 3 months and older. It should be used minimally and discontinued upon achieving disease control, with specific limitations on application areas noted.

  • flurandrenolide

    (Flurandrenolide)
    Taro Pharmaceuticals U.S.A., Inc.
    Flurandrenolide Cream is indicated for relieving inflammation and itching associated with corticosteroid-responsive skin conditions.

  • lamotrigine

    (Lamotrigine)
    Taro Pharmaceuticals U.S.A., Inc.
    Lamotrigine is indicated as adjunctive therapy for partial-onset seizures, primary generalized tonic-clonic seizures, and generalized seizures of Lennox-Gastaut syndrome in patients aged 2 and older. It is also used for maintenance treatment of bipolar I disorder, but not for acute mood episodes.

  • ondansetron

    (ondansetron hydrochloride)
    Taro Pharmaceuticals U.S.A., Inc.
    Ondansetron is indicated for preventing nausea and vomiting caused by highly and moderately emetogenic cancer chemotherapy, specific radiotherapy treatments, and postoperative settings.